Please complete this form relating to your transactions for Teladoc Health, Inc. (NYSE: TDOC) securities between March 3, 2016, and December 5, 2018, both dates inclusive (the “Class Period”).
You may also contact James Maro, Esq. at (484) 270-1453; or you may submit your information via email at firstname.lastname@example.org, or you may click here to print a PDF of this form.
On December 12, 2018, the initial complaint in this securities class action was filed against Teladoc Health, Inc. ("Teladoc" or the “Company”), and certain of Teladoc’s directors and officers, asserting violations of sections 10(b) and 20(a) of the Securities Exchange Act.
The complaint alleged that, throughout the class period, the defendants made materially false and misleading statements regarding the Company’s business, operational and compliance policies. Specifically, the defendants made false and/or misleading statements and/or failed to disclose that: (i) Teladoc's Chief Financial Officer (“CFO”) was engaged in an inappropriate sexual relationship with a subordinate; (ii) the CFO and this subordinate engaged in insider trading to provide themselves with undue benefits; (iii) the CFO caused the subordinate to receive promotions for which she was unqualified, thereby negatively impacting the Company’s operations; (iv) the Company’s enforcement of its own purported employment and trading policies were inadequate to prevent the foregoing conduct; and (v) as a result, the Company’s public statements were materially false and misleading at all relevant times.
This is a federal securities class action on behalf of those who purchased or otherwise acquired Teladoc securities between March 3, 2016, and December 5, 2018, inclusive.
Current Status of Case:
On June 25, 2019, Plaintiffs filed a second amended consolidated complaint (the “Amended Complaint”). On September 13, 2019, Defendants filed a Motion to Dismiss the Amended Complaint. On September 29, 2021, the Court granted Defendants’ Motion to Dismiss and ordered that the case be closed. This action has concluded.
If you wish to discuss this action or have any questions concerning this notice or your rights or interests with respect to these matters, please contact Kessler Topaz Meltzer & Check, LLP: James Maro, Esq. (484) 270-1453; or via e-mail at email@example.com. If you would like additional information about the suit, please click on the link "Submit Your Information" above and fill out the form as promptly as possible.